In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Akorn Inc.

www.akorn.com

Latest From Akorn Inc.

Lupin Adds To US Portfolio

The launch of injectable doxercalciferol and FDA approvals for mycophenolic acid delayed-release tablets and betamethasone dipropionate ointment could add some cheer to Lupin whose high-potential launches in the US have seen delays. However, analysts are not very enthused.

Launches Generic Drugs

Akorn Considers Bankruptcy Filing

Buried within its financial disclosure of a standstill agreement with creditors until 7 February, Akorn disclosed that it is considering whether to file for bankruptcy protection in the US.

Business Strategies United States

Price Rises Return Akorn To Sales Growth

Raising prices for certain product lines helped Akorn to post its first sales growth since 2016 as the US injectables and ophthalmics firm worked towards addressing two FDA warning letters.

Sales & Earnings Manufacturing

Supreme Court Refuses Inter Partes Review

Standards of evidence for obviousness used in US inter partes patent reviews will not be reviewed by the US Supreme Court. Nor will the court consider whether the Federal Circuit can confirm inter partes decisions without issuing an opinion.

Intellectual Property Legal Issues
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
    • Radiopharmaceuticals, Contrast Agents
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Akorn Inc.
  • Senior Management
  • Raj Rai, CEO
    Duane A Portwood, CFO
    Jonathan Kafer, EVP, Sales & Mktg.
    Bruce Kutinsky, PharmD, COO
    Steve Lichter, EVP, Pharma Ops
    Randall E Pollard, Chief Accounting Officer
  • Contact Info
  • Akorn Inc.
    Phone: (800) 932-5676
    1925 West Field Ct.
    Ste. 300
    Lake Forest, IL 60045
    USA
UsernamePublicRestriction

Register